{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:49:40Z","timestamp":1781610580075,"version":"3.54.5"},"reference-count":7,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.eururo.2018.09.039","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T01:02:35Z","timestamp":1538701355000},"page":"72-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Radiofrequency-induced Thermochemotherapy for Recurrent Non\u2013muscle-invasive Bladder Cancer: A New Treatment for an Unmet Need?"],"prefix":"10.1016","volume":"75","author":[{"given":"J. Alfred","family":"Witjes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2018.09.039_bib0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.eururo.2018.09.005","volume":"75","author":"Tan","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2018.09.039_bib0045","unstructured":"Babjuk M, Burger M, Comp\u00e9rat E, et al. EAU guideline on non-muscle-invasive bladder cancer. http:\/\/uroweb.org\/guideline\/non-muscle-invasive-bladder-cancer\/."},{"key":"10.1016\/j.eururo.2018.09.039_bib0050","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.eururo.2016.01.006","article-title":"Results of a randomised controlled trial comparing intravesical chemohyperthermia with mitomycin C versus bacillus Calmette-Gu\u00e9rin for adjuvant treatment of patients with intermediate- and high-risk non-muscle-invasive bladder cancer","volume":"69","author":"Arends","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2018.09.039_bib0055","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.juro.2014.03.101","article-title":"Combined chemohyperthermia: the 10-years monocentric experience in 160 non-muscle invasive bladder cancer patients","volume":"192","author":"Arends","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2018.09.039_bib0060","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.juro.2009.06.017","article-title":"Combined thermo-chemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin","volume":"182","author":"Nativ","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2018.09.039_bib0065","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3233\/BLC-180187","article-title":"Intravesical radiofrequency-induced chemohyperthermia for carcinoma in situ of the urinary bladder: a retrospective multicentre study","volume":"4","author":"Valenberg","year":"2018","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.eururo.2018.09.039_bib0070","unstructured":"US Food and Drug Administration. BCG-unresponsive nonmuscle invasive bladder cancer: developing drugs and biologics for treatment guidance for industry. www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM529600.pdf."}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283818307279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283818307279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T14:09:38Z","timestamp":1567174178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283818307279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0302283818307279"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2018.09.039","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiofrequency-induced Thermochemotherapy for Recurrent Non\u2013muscle-invasive Bladder Cancer: A New Treatment for an Unmet Need?","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2018.09.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2018.09.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}